353 related articles for article (PubMed ID: 32012897)
1. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
[TBL] [Abstract][Full Text] [Related]
2. Impact of the Secretome of Human Mesenchymal Stem Cells on Brain Structure and Animal Behavior in a Rat Model of Parkinson's Disease.
Teixeira FG; Carvalho MM; Panchalingam KM; Rodrigues AJ; Mendes-Pinheiro B; Anjo S; Manadas B; Behie LA; Sousa N; Salgado AJ
Stem Cells Transl Med; 2017 Feb; 6(2):634-646. PubMed ID: 28191785
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.
Chen D; Fu W; Zhuang W; Lv C; Li F; Wang X
J Neurosci Res; 2017 Mar; 95(3):907-917. PubMed ID: 27617772
[TBL] [Abstract][Full Text] [Related]
4. Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats.
Suzuki S; Kawamata J; Iwahara N; Matsumura A; Hisahara S; Matsushita T; Sasaki M; Honmou O; Shimohama S
Neurosci Lett; 2015 Jan; 584():276-81. PubMed ID: 25449872
[TBL] [Abstract][Full Text] [Related]
5. Bone Marrow Mesenchymal Stem Cells' Secretome Exerts Neuroprotective Effects in a Parkinson's Disease Rat Model.
Mendes-Pinheiro B; Anjo SI; Manadas B; Da Silva JD; Marote A; Behie LA; Teixeira FG; Salgado AJ
Front Bioeng Biotechnol; 2019; 7():294. PubMed ID: 31737616
[TBL] [Abstract][Full Text] [Related]
6. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
7. Combination of Human Mesenchymal Stem Cells and Repetitive Transcranial Magnetic Stimulation Enhances Neurological Recovery of 6-Hydroxydopamine Model of Parkinsonian's Disease.
Lee JY; Kim HS; Kim SH; Kim HS; Cho BP
Tissue Eng Regen Med; 2020 Feb; 17(1):67-80. PubMed ID: 31970698
[TBL] [Abstract][Full Text] [Related]
8. Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease.
Kim HW; Lee HS; Kang JM; Bae SH; Kim C; Lee SH; Schwarz J; Kim GJ; Kim JS; Cha DH; Kim J; Chang SW; Lee TH; Moon J
Cell Transplant; 2018 May; 27(5):814-830. PubMed ID: 29871515
[TBL] [Abstract][Full Text] [Related]
9. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
Hoban DB; Howard L; Dowd E
Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
[TBL] [Abstract][Full Text] [Related]
10. Physical exercise and human adipose-derived mesenchymal stem cells ameliorate motor disturbances in a male rat model of Parkinson's disease.
Cucarián JD; Berrío JP; Rodrigues C; Zancan M; Wink MR; de Oliveira A
J Neurosci Res; 2019 Sep; 97(9):1095-1109. PubMed ID: 31119788
[TBL] [Abstract][Full Text] [Related]
11. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine.
Chierchia A; Chirico N; Boeri L; Raimondi I; Riva GA; Raimondi MT; Tunesi M; Giordano C; Forloni G; Albani D
Eur J Pharm Biopharm; 2017 Dec; 121():113-120. PubMed ID: 28965958
[TBL] [Abstract][Full Text] [Related]
12. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.
Wang F; Yasuhara T; Shingo T; Kameda M; Tajiri N; Yuan WJ; Kondo A; Kadota T; Baba T; Tayra JT; Kikuchi Y; Miyoshi Y; Date I
BMC Neurosci; 2010 Apr; 11():52. PubMed ID: 20420688
[TBL] [Abstract][Full Text] [Related]
13. Intranasal Administration of Extracellular Vesicles Derived from Human Teeth Stem Cells Improves Motor Symptoms and Normalizes Tyrosine Hydroxylase Expression in the Substantia Nigra and Striatum of the 6-Hydroxydopamine-Treated Rats.
Narbute K; Piļipenko V; Pupure J; Dzirkale Z; Jonavičė U; Tunaitis V; Kriaučiūnaitė K; Jarmalavičiūtė A; Jansone B; Kluša V; Pivoriūnas A
Stem Cells Transl Med; 2019 May; 8(5):490-499. PubMed ID: 30706999
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of bone marrow-derived mesenchymal stem cell secretome in 6-OHDA-induced Parkinson's disease.
Mahendru D; Jain A; Bansal S; Malik D; Dhir N; Sharma AR; Sarma P; Prakash A; Nahar U; Bhatia A; Bhattacharyya S; Medhi B
Regen Med; 2021 Oct; 16(10):915-930. PubMed ID: 34553608
[No Abstract] [Full Text] [Related]
15. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potentials of human microfluidic encapsulated conjunctival mesenchymal stem cells on the rat model of Parkinson's disease.
Forouzandeh M; Bigdeli MR; Mostafavi H; Nadri S; Eskandari M
Exp Mol Pathol; 2021 Dec; 123():104703. PubMed ID: 34619140
[TBL] [Abstract][Full Text] [Related]
17. Treating Parkinson's Disease with Human Bone Marrow Mesenchymal Stem Cell Secretome: A Translational Investigation Using Human Brain Organoids and Different Routes of In Vivo Administration.
Mendes-Pinheiro B; Campos J; Marote A; Soares-Cunha C; Nickels SL; Monzel AS; Cibrão JR; Loureiro-Campos E; Serra SC; Barata-Antunes S; Duarte-Silva S; Pinto L; Schwamborn JC; Salgado AJ
Cells; 2023 Nov; 12(21):. PubMed ID: 37947643
[TBL] [Abstract][Full Text] [Related]
18. Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease.
Mendes-Pinheiro B; Teixeira FG; Anjo SI; Manadas B; Behie LA; Salgado AJ
Stem Cells Transl Med; 2018 Nov; 7(11):829-838. PubMed ID: 30238668
[TBL] [Abstract][Full Text] [Related]
19. Fractionating stem cells secretome for Parkinson's disease modeling: Is it the whole better than the sum of its parts?
Vilaça-Faria H; Marote A; Lages I; Ribeiro C; Mendes-Pinheiro B; Domingues AV; Campos J; Lanceros-Mendez S; Salgado AJ; Teixeira FG
Biochimie; 2021 Oct; 189():87-98. PubMed ID: 34182001
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.
Danielyan L; Schäfer R; von Ameln-Mayerhofer A; Bernhard F; Verleysdonk S; Buadze M; Lourhmati A; Klopfer T; Schaumann F; Schmid B; Koehle C; Proksch B; Weissert R; Reichardt HM; van den Brandt J; Buniatian GH; Schwab M; Gleiter CH; Frey WH
Rejuvenation Res; 2011 Feb; 14(1):3-16. PubMed ID: 21291297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
